TWI
Titan InternationalDAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
The post-print reaction was sharply negative: TWI fell from $6.62 on October 28 to $4.91 on October 29 (-25.8%), closed at $4.65 on October 30, then recovered to the packet's $4.97 November 2 anchor (historical prices). The guidance cut and weak Agricultural segment provide a plausible explanation, but the sources do not isolate the cause of the move. One maintained analyst rating is identifiable; broader post-earnings target and estimate revisions are unavailable. Social, options, short-interest, and employee-sentiment data are unavailable; the zero fields above denote missing data, not neutral readings.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Titan cut its FY2026 adjusted EBITDA outlook from $105 million–$115 million to $91 million–$101 million and now expects Q4 adjusted EBITDA between breakeven and $7 million, inclusive of ITM. Delivery against that narrow Q4 range is the next test of whether the earnings reset is sufficient [#8-K-2026-10-29] [#SEC-8K-2026-10-29].
Titan expects to close its agreed ITM sale to USCO in early January 2027 and intends to use part of the proceeds to reduce debt. The September agreement specifies approximately $207 million in cash, subject to adjustments, plus a possible $6 million earnout. Regulatory and other closing conditions remain outstanding; the sale is not completed [#SEC-8K-2026-10-29] [#SEC-8K-2026-09-21].
Management sees an aging machinery fleet and low distribution-channel wheel and tire inventories as potential supports for recovery, but Q3 Agricultural sales fell 12% amid weak farmer spending. Sustained order and margin improvement—not the inventory thesis alone—would be needed to validate a recovery [#EARNINGS-TRANSCRIPT-2026Q3] [#SEC-8K-2026-10-29].
Recommendation
No formal recommendation provided.

